Spine devicemaker Carlsmed saw massive year-over-year leaps in its first quarter revenue, according to financial results posted May 5.
Five things to know:
1. First-quarter revenue reached $16.1 million, a 58% increase year over year.
2. Carlsmed saw gross profit of $12.4 million, up from $7.6 million during the same period in 2025.
3. Operating expenses grew to $21.7 million in the first quarter and include research and development, sales and marketing and general costs.
4. Carlsmed operated on a quarterly net loss of $8.7 million.
5. The company expects full-year 2026 revenue to be in the range of $72 million to $77 million.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
